The Artificial Heart market is a subset of the Cardiovascular Devices market, which includes a variety of medical devices used to treat heart conditions. Artificial Hearts are mechanical devices that are implanted into a patient's body to replace a failing heart. These devices are typically used as a bridge to heart transplantation, providing a temporary solution for patients with end-stage heart failure. Artificial Hearts are designed to mimic the natural functions of the heart, such as pumping blood and regulating blood pressure. The Artificial Heart market is highly competitive, with a number of companies offering a range of products. Companies in the market include Abiomed, SynCardia Systems, Carmat, and WorldHeart Corporation. These companies are focused on developing innovative Artificial Heart technologies to improve patient outcomes and reduce healthcare costs. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
